SUTAB is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Braintree Laboratories, Inc.. The primary component is Sodium Sulfate; Magnesium Sulfate Anhydrous; Potassium Chloride.
| Product ID | 52268-201_b48ca5eb-f031-b60b-e053-2a95a90a5ee2 |
| NDC | 52268-201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SUTAB |
| Generic Name | Sodium Sulfate, Magnesium Sulfate, And Potassium Chloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-11-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA213135 |
| Labeler Name | Braintree Laboratories, Inc. |
| Substance Name | SODIUM SULFATE; MAGNESIUM SULFATE ANHYDROUS; POTASSIUM CHLORIDE |
| Active Ingredient Strength | 18 g/1; g/1; g/1 |
| Pharm Classes | Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-11-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SUTAB 88656899 not registered Live/Pending |
Sebela BT Holdings, Inc. 2019-10-16 |
![]() SUTAB 88656848 not registered Live/Pending |
Sebela BT Holdings, Inc. 2019-10-16 |